Ventas, Inc.
NYSE:VTRREIT - Healthcare Facilities
-$0.28 today
- Market cap
- $46.64B
- Beta
- 0.73
- P/E (TTM)
- 149.7
- EPS (TTM)
- $0.55
- Dividend yield
- 2.39%
Volume 3.72M
Average 4.09M
VTR Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Ventas, Inc.NYSE: VTR
Operating Expenses · Q2 FY2026 · quarter ended Jun 2026
Operating expenses growth accelerates
Q2 FY2026 operating expenses of $472.7M rose 21.0% year over year, ahead of the -168.7% change in trailing-twelve-month operating expenses. Sequentially, it rose 1.9% from the prior quarter.
Context
- Operating expenses amounted to 20.1% of revenue in FY2025, down 8.7 pp from a year earlier.
- Operating expenses increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.0% holds above the trailing-twelve-month pace of -168.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- (1.17B) USD
- Year-over-year change
- -182.7%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.17B) | -182.7% |
| FY2024 | 2024-12-31 | 1.42B | -6.9% |
| FY2023 | 2023-12-31 | 1.52B | +11.6% |
| FY2022 | 2022-12-31 | 1.36B | +3.4% |
| FY2021 | 2021-12-31 | 1.32B | — |
Operating Expenses vs competitors
How VTR compares with its peers on the latest reported figures
- VTR's LTM Jun 2026 operating expenses of -$999.72M is the lowest of the 11 companies compared; the peer median is $122.2M.
- Its year-over-year change of -168.7% is the lowest of 10, against a peer median of -16.6%.
- Operating expenses amounts to 15.5% of revenue for VTR, versus a peer median of 25.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $5.89B | +166.6% | +37.5% | 43.0% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $413.78M | -11.8% | -7.1% | 40.6% |
| LTM Jun 2026 | $400.01M | +79.6% | +1.8% | 46.5% | |
| LTM Sep 2026 | $246.8M | -13.6% | +6.7% | 9.2% | |
| LTM Jun 2026 | $123.67M | -69.6% | — | 9.6% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $120.73M | — | -7.9% | 35.3% |
| LTM Sep 2026 | $85.47M | -35.5% | — | 13.9% | |
| LTM Sep 2026 | $76.92M | -16.6% | +5.3% | 19.5% | |
| LTM Sep 2026 | $48.95M | -69.6% | — | 10.7% | |
| LTM Sep 2026 | -$703.38M | -160.5% | -52.5% | 31.3% | |
| LTM Jun 2026 | -$999.72M | -168.7% | — | 15.5% | |
| Peer median (excluding VTR) | $122.2M | -16.6% | +1.8% | 25.4% | |
Competitors are the stored peer set for VTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.83B | 4.13B | 4.5B | 4.92B | 5.83B |
| Cost of Revenue | 2.09B | 2.28B | 2.56B | 2.83B | 6.18B |
| Gross Profit | 1.74B | 1.85B | 1.94B | 2.1B | (344.22M) |
| Gross Margin | 45.4% | 44.7% | 43.1% | 42.6% | -5.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 129.76M | 144.87M | 148.88M | 162.99M | 177.4M |
| Operating Expenses | 1.32B | 1.36B | 1.52B | 1.42B | (1.17B) |
| Depreciation & Amortization | 978M | 1.09B | 1.17B | 1.17B | 1.38B |
| EBITDA | 1.48B | 1.5B | 1.7B | 1.82B | 2.24B |
| EBITDA Margin | 38.6% | 36.3% | 37.8% | 37.0% | 38.4% |
| Operating Income | 421.43M | 483.85M | 415.51M | 681.23M | 826.81M |
| Operating Margin | 11.0% | 11.7% | 9.2% | 13.8% | 14.2% |
| Interest Income | 0 | 0 | 0 | 0 | 22.59M |
| Interest Expense | 440.09M | 467.56M | 574.11M | 602.84M | 612.25M |
| Other Income / Expenses | (360.05M) | (541.7M) | (455.35M) | (630.65M) | (579.44M) |
| Income Before Tax | 61.39M | (57.86M) | (39.84M) | 50.58M | 247.37M |
| Pre-Tax Margin | 1.6% | -1.4% | -0.9% | 1.0% | 4.2% |
| Income Tax Expense | 4.83M | (16.93M) | (9.54M) | (37.78M) | (14.15M) |
| Net Income | 49.01M | (47.45M) | (40.97M) | 81.15M | 251.38M |
| Net Margin | 1.3% | -1.1% | -0.9% | 1.6% | 4.3% |
| EPS (Basic) | 0.13 | (0.13) | (0.10) | 0.20 | 0.55 |
| EPS (Diluted) | 0.13 | (0.13) | (0.10) | 0.19 | 0.54 |
| Weighted Avg Shares | 382.79M | 373.37M | 401.81M | 411.77M | 455.08M |
| Weighted Avg Shares (Diluted) | 386.3M | 373.37M | 405.67M | 416.37M | 462.62M |
Ventas, Inc.
NYSE:VTR
Intrinsic Alpha fair value
Locked
Current Price
$88.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.